CEACAM5 and gastric cancer: In gastric cancer, several groups have suggested that markers such as CEA, CA19-9 and CA125 in ascitic fluid may help reveal peritoneal involvement when cytology is negative, potentially supporting earlier therapeutic decisions [39,49].